Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2024 Jun 7;70(suppl 1):e2024S107.
doi: 10.1590/1806-9282.2024S107. eCollection 2024.

Pre-operative imaging evaluation of renal cell carcinoma

Paulo Victor Alves Pinto  1 , Fernando Morbeck Almeida Coelho  1 , Alice Schuch  2 , Mauricio Zapparoli  3 , Ronaldo Hueb Baroni  1
Affiliations
Practice Guideline

Pre-operative imaging evaluation of renal cell carcinoma

Paulo Victor Alves Pinto et al. Rev Assoc Med Bras (1992). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: the authors declare there is no conflicts of interest.

Figures

Figure 1
Figure 1. Imaging features of the clear-cell renal cell carcinoma subtype. (A, F) (T2WI), and (B) (fat-sat T2WI) show a heterogeneous lesion with liquefied or necrotic areas. (C) (CT) and (D) (magnetic resonance imaging) images show hyperenhancement in the corticomedullary phase, simillar to (E) (magnetic resonance imaging). (G) and (H) images demonstrate signal drop on opposed-phase imaging, demonstrating intralesional microscopic fat.
Figure 2
Figure 2. Papillary (A–D) and chromophobe RCC (E–H) features. PRCC is shown in (A) (T2WI imaging) as a homogeneous intermediate signal nodular lesion, hypovascular on (B) (CECT), and presenting marked diffusion-weighted imaging restriction (C) and low signal on the ADC map (D). Chromophobe RCC features are shown on (E–H) as a large heterogeneous lesion, hypovascular, with a central scar.
Figure 3
Figure 3. Clear-cell likelihood score evaluation flowchart. Adapted from Pedrosa et.al..
See this image and copyright information in PMC

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. doi: 10.3322/caac.21763. - DOI - PubMed
    1. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA. The natural history of incidentally detected small renal masses. Cancer. 2004;100(4):738–745. doi: 10.1002/cncr.20025. - DOI - PubMed
    1. National Comprehensive Cancer Network . NCCN clinical practice guidelines in oncology (NCCN Guidelines®) for guideline name kidney cancer.1.2024. Plymouth (PA): National Comprehensive Cancer Network, Inc©; 2023. - PubMed
    1. IARC Publications . Urinary and male genital tumours. WHO classification of tumours. 5th ed. Vol. 8. Geneva: WHO; 2022.

Publication types

MeSH terms